{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:48:55Z","timestamp":1789102135759,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2010]]},"DOI":"10.1007\/s10156-010-0071-7","type":"journal-article","created":{"date-parts":[[2010,6,9]],"date-time":"2010-06-09T05:08:18Z","timestamp":1276060098000},"page":"388-395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Comparative study of the efficacy of liposomal amphotericin B and amphotericin B deoxycholate against six species of Zygomycetes in a murine lethal infection model"],"prefix":"10.1016","volume":"16","author":[{"given":"Koji","family":"Takemoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Kanazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s10156-010-0071-7_bib0005","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/339202","article-title":"Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients","volume":"34","author":"Marr","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1007\/s10156-010-0071-7_bib0010","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1086\/375822","article-title":"Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi","volume":"37","author":"Husain","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1007\/s10156-010-0071-7_bib0015","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1086\/428780","article-title":"Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases","volume":"191","author":"Kontoyiannis","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1007\/s10156-010-0071-7_bib0020","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1007\/s10156-010-0071-7_bib0025","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10096-006-0107-1","article-title":"Zygomycosis: the re-emerging fungal infection","volume":"25","author":"Chayakulkeeree","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1007\/s10156-010-0071-7_bib0030","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1128\/CMR.18.3.556-569.2005","article-title":"Novel perspectives on mucormycosis: pathophysiology, presentation, and management","volume":"18","author":"Spellberg","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1007\/s10156-010-0071-7_bib0035","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1086\/423274","article-title":"Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole","volume":"39","author":"Imhof","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1007\/s10156-010-0071-7_bib0040","first-page":"ECR42","article-title":"Breakthrough zygomycosis during voriconazole treatment for invasive aspergillosis","volume":"89","author":"Kobayashi","year":"2004","journal-title":"Haematologica"},{"key":"10.1007\/s10156-010-0071-7_bib0045","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/427759","article-title":"Breakthrough zygomycosis during empirical voriconazole therapy in febrile patients with neutropenia","volume":"40","author":"Oren","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1007\/s10156-010-0071-7_bib0050","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1086\/427752","article-title":"Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required","volume":"40","author":"Vigouroux","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1007\/s10156-010-0071-7_bib0055","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.bmt.1705614","article-title":"Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy","volume":"39","author":"Trifilio","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1007\/s10156-010-0071-7_bib0060","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1086\/597615","article-title":"Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis","volume":"199","author":"Lamaris","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1007\/s10156-010-0071-7_bib0065","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1128\/AAC.00452-07","article-title":"In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents","volume":"51","author":"Almyroudis","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s10156-010-0071-7_bib0070","series-title":"The sanford guide to antimicrobial therapy","author":"Gilbert","year":"2009"},{"key":"10.1007\/s10156-010-0071-7_bib0075","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1080\/10428190310001653691","article-title":"Improved outcome of zygomycosis in patients with hematological diseases?","volume":"45","author":"Gleissner","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1007\/s10156-010-0071-7_bib0080","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1128\/AAC.47.10.3343-3344.2003","article-title":"Liposomal amphotericin B, and not amphotericin B deoxycholate, improves survival of diabetic mice infected with Rhizopus oryzae","volume":"47","author":"Ibrahim","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s10156-010-0071-7_bib0085","series-title":"Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A2","year":"2008"},{"key":"10.1007\/s10156-010-0071-7_bib0090","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/jac\/dkh055","article-title":"Comparative studies on the efficacy of AmBisome and Fungizone in a mouse model of disseminated aspergillosis","volume":"53","author":"Takemoto","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1007\/s10156-010-0071-7_bib0095","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/jac\/dkg020","article-title":"In vitro susceptibilities of zygomycetes to conventional and new antifungals","volume":"51","author":"Dannaoui","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1007\/s10156-010-0071-7_bib0100","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1023\/A:1010954803886","article-title":"In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature","volume":"150","author":"Espinel-Ingroff","year":"2001","journal-title":"Mycopathologia"},{"key":"10.1007\/s10156-010-0071-7_bib0105","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1128\/AAC.00456-09","article-title":"Efficacy of liposomal amphotericin B combined with gamma interferon or granulocyte-macrophage colony-stimulating factor for treatment of systemic zygomycosis in mice","volume":"53","author":"Rodr\u00edguez","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s10156-010-0071-7_bib0110","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1128\/AAC.01458-07","article-title":"Combination echinocandin-polyene treatment of murine mucormycosis","volume":"52","author":"Ibrahim","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s10156-010-0071-7_bib0115","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1023\/A:1007095831301","article-title":"A murine model of zygomycosis by Cunninghamella bertholletiae","volume":"144","author":"Honda","year":"1998","journal-title":"Mycopathologia"},{"key":"10.1007\/s10156-010-0071-7_bib0120","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/590004","article-title":"Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis","volume":"47","author":"Chamilos","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1007\/s10156-010-0071-7_bib0125","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s10156-008-0657-5","article-title":"Breakthrough disseminated zygomycosis induced massive gastrointestinal bleeding in a patient with acute myeloid leukemia receiving micafungin","volume":"15","author":"Suzuki","year":"2009","journal-title":"J Infect Chemother"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X10705602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X10705602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10156-010-0071-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:47:26Z","timestamp":1761158846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X10705602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010]]}},"alternative-id":["S1341321X10705602"],"URL":"https:\/\/doi.org\/10.1007\/s10156-010-0071-7","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative study of the efficacy of liposomal amphotericin B and amphotericin B deoxycholate against six species of Zygomycetes in a murine lethal infection model","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s10156-010-0071-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}